Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Oxycodone hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
OxyContin 40mg modified-release tablets
0407020ADBCACAH
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 1,206 |
|
Reltebon 10mg modified-release tablets
0407020ADBKABAF
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,191 |
|
Oxycodone 20mg/2ml solution for injection ampoules
0407020ADAAAMAM
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,153 |
|
Oxycodone 80mg modified-release tablets
0407020ADAAAIAI
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,075 |
|
Oxycodone 50mg/1ml solution for injection ampoules
0407020ADAAANAN
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 1,050 |
|
Reltebon 20mg modified-release tablets
0407020ADBKACAG
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 1,047 |
|
Lynlor 20mg capsules
0407020ADBHACAE
|
Lynlor | Oxycodone hydrochloride | Central Nervous System | 1,016 |
|
OxyContin 30mg modified-release tablets
0407020ADBCAHAR
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 968 |
|
Oxeltra 80mg modified-release tablets
0407020ADBLABAI
|
Oxeltra | Oxycodone hydrochloride | Central Nervous System | 838 |
|
OxyNorm 20mg capsules
0407020ADBBAEAE
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 795 |
|
OxyNorm 10mg/ml concentrate oral solution
0407020ADBBABAB
|
OxyNorm | Oxycodone hydrochloride | Central Nervous System | 760 |
|
Oxylan 10mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFABAF
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 637 |
|
OxyContin 80mg modified-release tablets
0407020ADBCADAI
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 597 |
|
Oxycodone 10mg tablets
0407020ADAAAUAU
|
Oxycodone hydrochloride | Oxycodone hydrochloride | Central Nervous System | 592 |
|
Reltebon 5mg modified-release tablets
0407020ADBKAAAK
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 546 |
|
Oxylan 5mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAAAK
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 541 |
|
OxyContin 15mg modified-release tablets
0407020ADBCAIAS
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 520 |
|
Reltebon 40mg modified-release tablets
0407020ADBKADAH
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 499 |
|
Oxylan 20mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFACAG
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 439 |
|
Reltebon 15mg modified-release tablets
0407020ADBKAFAS
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 407 |
|
Reltebon 30mg modified-release tablets
0407020ADBKAGAR
|
Reltebon | Oxycodone hydrochloride | Central Nervous System | 402 |
|
OxyContin 60mg modified-release tablets
0407020ADBCAGAQ
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 392 |
|
Renocontin 10mg modified-release tablets
0407020ADBRABAF
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 346 |
|
Renocontin 20mg modified-release tablets
0407020ADBRADAG
|
Renocontin | Oxycodone hydrochloride | Central Nervous System | 286 |
|
Oxyact 5mg tablets
0407020ADBUACAT
|
Oxyact | Oxycodone hydrochloride | Central Nervous System | 261 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.